The growth and maturation of the Winship Cancer Institute (Winship) as a new CCSG-supported cancer center requires the development of a strong and highly effective administration. The past two years have witnessed a full administrative reorganization and new personnel recruitment to Winship's administrative team. These transitions were accomplished as a process fully integrated with the development of the Winship Strategic Plan 2010-2015. The current capabilities and responsibilities of the Winship administrative team include the following roles: * Planning and evaluation activities to promote interdisciplinary and translational research * Financial management of all Winship funds and accounts * Shared resource management including budgetary oversight, rate structuring, and reporting * Management of Winship's facilities, space, and equipment * Support and coordination of membership applications and review processes * Coordination of information technology and informatics needs * Communications, development, public affairs, and education programs * Personnel management and human resource services * Management and coordination of Winship pilot grant program * Executive support to all Winship committees within the cancer center's enhanced organizational structure To fulfill its vision, Winship must expand its research enterprise, and highly effective administrative support will be critical in achieving this. Winship has the appropriate administrative processes to manage the cancer center's growth and a highly skilled administrative team to implement its strategic plan.
Winship administration provides direct grant, research, space, and other administrative services to 146 cancer center members and five shared resource facilities. The administrative team will optimize CCSG funds to continue to facilitate cancer research and manage Winship's essential operations.
|Bilen, Mehmet Asim; Dutcher, Giselle Marie Almeida; Liu, Yuan et al. (2018) Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clin Genitourin Cancer 16:e563-e575|
|Chowdhary, Mudit; Switchenko, Jeffrey M; Press, Robert H et al. (2018) Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neurooncol 139:689-697|
|Morgan, T M; Wang, X; Qian, X et al. (2018) Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes. Clin Transl Oncol :|
|Lin, Songbai; Han, Yiran; Jenkin, Kayte et al. (2018) Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis. Am J Pathol 188:353-366|
|Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5|
|Bekhbat, Mandakh; Chu, Karen; Le, Ngoc-Anh et al. (2018) Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology 98:222-229|
|Felger, Jennifer C; Haroon, Ebrahim; Patel, Trusharth A et al. (2018) What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry :|
|Akce, Mehmet; Zaidi, Mohammad Y; Waller, Edmund K et al. (2018) The Potential of CAR T Cell Therapy in Pancreatic Cancer. Front Immunol 9:2166|
|Greenwell, I Brian; Staton, Ashley D; Lee, Michael J et al. (2018) Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Cancer 124:2306-2315|
|Hou, Yue; Konen, Jessica; Brat, Daniel J et al. (2018) TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics. Sci Rep 8:7248|
Showing the most recent 10 out of 331 publications